Gastrointestinal stromal tumour a review of literature: Difference between revisions

From Top Italian Scientists Journal
(Created blank page)
 
No edit summary
Line 1: Line 1:
{{DISPLAYTITLE:Gastrointestinal stromal tumour: a review of literature}}{{#seo:
|title=Gastrointestinal stromal tumour: a review of literature - Top Italian Scientists Journal
|description=Gastrointestinal stromal tumours (GIST) are the most common of the rare non-epithelial neoplasms of the gastrointestinal tract, accounting for 0.1–3% of gastrointestinal malignancies.
|keywords=gastrointestinal stromal tumour; metastatic tumour; surgery, laparoscopy, GIST.
|citation_author=Pappalardo,Vincenzo; Morabito,Marika; Gianazza, Simone; Milani, Marika S.; Bardelli, Laura; Coriele, Silvia; Liepa, Linda; Fabbi, Manrica; Pavesi, Franco; Rocchi, Paolo; Reggiori, Alberto; Ardita, Vincenzo; Rausei, Stefano           
|citation_journal_title=Top Italian Scientists Journal
|citation_publication_date=2024/09/11
|citation_title=Gastrointestinal stromal tumour: a review of literature
|citation_keywords=gastrointestinal stromal tumour; metastatic tumour; surgery, laparoscopy, GIST.
|citation_publisher=Top Italian Scientists
|citation_volume=1
|citation_issue=4
|citation_doi=10.62684/PAWU8603
|citation_issn=3033-5132
|}}{| class="wikitable" style="float:right ;border:solid 1px #a2a9b1; background-color: #f8f9fa" cellpadding="5"
|+ <span style="font-size:18px;"></span>
|-
| '''Published'''
|-
| September 11, 2024
|-
| '''Title'''
|-
| style="width:200px;" | Gastrointestinal stromal tumour: a review of literature
|-
| '''Authors'''
|-
|  Vincenzo Pappalardo, Marika Morabito, Simone Gianazza,  Marika S. Milani, Laura Bardelli, Silvia Coriele, Linda Liepa, Manrica Fabbi, Franco Pavesi, Paolo Rocchi, Alberto Reggiori, Vincenzo Ardita, Stefano Rausei.
|-
| '''DOI'''
|-
| [https://doi.org/10.62684/PAWU8603 10.62684/PAWU8603]
|-
| '''Keywords'''
|-
| Gastrointestinal stromal tumour; metastatic tumour; surgery, laparoscopy, GIST.
|-
| '''Downloads'''
|-
|  style="text-align: center;" | [[File:PDF_file_icon.png|center|50px|'''Download PDF'''|link=https://journal.topitalianscientists.org/images/9/9a/Gastrointestinal_stromal_tumour_a_review_of_literature.pdf]]
|}
'''Vincenzo Pappalardo'''<sup>(a)</sup>, '''Marika Morabito'''<sup>(b)</sup>, '''Simone Gianazza'''<sup>(b)</sup>,  '''Marika S. Milani'''<sup>(a)</sup>, '''Laura Bardelli'''<sup>(a)</sup>, '''Silvia Coriele'''<sup>(a)</sup>, '''Linda Liepa'''<sup>(b)</sup>, '''Manrica Fabbi'''<sup>(a)</sup>, '''Franco Pavesi'''<sup>(a)</sup>, '''Paolo Rocchi'''<sup>(a)</sup>, '''Alberto Reggiori'''<sup>(a)</sup>, '''Vincenzo Ardita'''<sup>(c)</sup>, '''[https://www.topitalianscientists.org/tis/49138/Stefano_Rausei_-_Top_Italian_Scientist_in_Clinical_Sciences Stefano Rausei]'''<sup>(a)</sup>.


<sup>(a)</sup> Department of Surgery, Cittiglio-Angera Hospital - ASST Sette Laghi, Varese, Italy.
<sup>(b)</sup> General, Emergency, and Transplant Surgery Unit, University of Insubria, ASST Settelaghi, Varese, Italy.
<sup>(c)</sup> Vein Center, Vascular Surgery Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
''Correspondence to'': Pappalardo Vincenzo, vincenzopappalardo1@gmail.com.
==Abstract==
Gastrointestinal stromal tumours (GIST) are the most common of the rare non-epithelial neoplasms of the gastrointestinal tract, accounting for 0.1–3% of gastrointestinal malignancies. They were considered smooth muscle sarcomas until being recognized as a distinct disease in the 1990s. Interstitial cell of Cajal (ICC), also called gastrointestinal pacemaker cell, regulates the gastrointestinal tract peristalsis and is proposed to be the cell of origin for GIST. [1] The majority (95%) of GISTs are driven by gain-of-function mutations in receptor tyrosine kinases that are encoded by the proto-oncogene KIT. Various clinical trials have demonstrated the efficacy of tyrosine kinase inhibitors (TKIs) in the treatment of GISTs, including metastatic disease. The leading treatment for GIST cases remains surgical resection. Standard first-line therapy for inoperable, metastatic or recurrent disease is the tyrosine-kinase inhibitor Imatinib. With the development of laparoscopic techniques and instruments, laparoscopy has rapidly become a preferred approach, especially for gGISTs. The indication for a laparoscopic procedure depends on the location, shape and size of the gGIST. The latest National Comprehensive Cancer Network (NCCN) and European Society for Medical Oncology (ESMO) Guidelines suggest that a laparoscopic resection may be considered for gGISTs in favourable anatomic locations (such as the greater curvature or anterior wall of the stomach) and discourage its use in patients who have large tumours. We have done a non-systematic review of the literature of GISTs, focusing on the use of laparoscopic treatment and  all the chemotherapeutic drugs available nowadays. The purpose of this work  is to review the past year's literature to provide comprehensive information to researchers and physicians regarding the epidemiology, diagnosis, and treatment of GISTs, enabling clinicians to best select the diagnostic and treatment approaches to GIST.
==Declarations==
===Conflict of Interest===
The Authors declare that there is no conflict of interest.

Revision as of 14:35, 11 September 2024

Published
September 11, 2024
Title
Gastrointestinal stromal tumour: a review of literature
Authors
Vincenzo Pappalardo, Marika Morabito, Simone Gianazza, Marika S. Milani, Laura Bardelli, Silvia Coriele, Linda Liepa, Manrica Fabbi, Franco Pavesi, Paolo Rocchi, Alberto Reggiori, Vincenzo Ardita, Stefano Rausei.
DOI
10.62684/PAWU8603
Keywords
Gastrointestinal stromal tumour; metastatic tumour; surgery, laparoscopy, GIST.
Downloads
Download PDF
Download PDF

Vincenzo Pappalardo(a), Marika Morabito(b), Simone Gianazza(b), Marika S. Milani(a), Laura Bardelli(a), Silvia Coriele(a), Linda Liepa(b), Manrica Fabbi(a), Franco Pavesi(a), Paolo Rocchi(a), Alberto Reggiori(a), Vincenzo Ardita(c), Stefano Rausei(a).


(a) Department of Surgery, Cittiglio-Angera Hospital - ASST Sette Laghi, Varese, Italy.

(b) General, Emergency, and Transplant Surgery Unit, University of Insubria, ASST Settelaghi, Varese, Italy.

(c) Vein Center, Vascular Surgery Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Correspondence to: Pappalardo Vincenzo, vincenzopappalardo1@gmail.com.

Abstract

Gastrointestinal stromal tumours (GIST) are the most common of the rare non-epithelial neoplasms of the gastrointestinal tract, accounting for 0.1–3% of gastrointestinal malignancies. They were considered smooth muscle sarcomas until being recognized as a distinct disease in the 1990s. Interstitial cell of Cajal (ICC), also called gastrointestinal pacemaker cell, regulates the gastrointestinal tract peristalsis and is proposed to be the cell of origin for GIST. [1] The majority (95%) of GISTs are driven by gain-of-function mutations in receptor tyrosine kinases that are encoded by the proto-oncogene KIT. Various clinical trials have demonstrated the efficacy of tyrosine kinase inhibitors (TKIs) in the treatment of GISTs, including metastatic disease. The leading treatment for GIST cases remains surgical resection. Standard first-line therapy for inoperable, metastatic or recurrent disease is the tyrosine-kinase inhibitor Imatinib. With the development of laparoscopic techniques and instruments, laparoscopy has rapidly become a preferred approach, especially for gGISTs. The indication for a laparoscopic procedure depends on the location, shape and size of the gGIST. The latest National Comprehensive Cancer Network (NCCN) and European Society for Medical Oncology (ESMO) Guidelines suggest that a laparoscopic resection may be considered for gGISTs in favourable anatomic locations (such as the greater curvature or anterior wall of the stomach) and discourage its use in patients who have large tumours. We have done a non-systematic review of the literature of GISTs, focusing on the use of laparoscopic treatment and all the chemotherapeutic drugs available nowadays. The purpose of this work is to review the past year's literature to provide comprehensive information to researchers and physicians regarding the epidemiology, diagnosis, and treatment of GISTs, enabling clinicians to best select the diagnostic and treatment approaches to GIST.

Declarations

Conflict of Interest

The Authors declare that there is no conflict of interest.

Retrieved from ‘https://journal.topitalianscientists.org/index.php?title=Gastrointestinal_stromal_tumour_a_review_of_literature&oldid=1554’